Matthew D. Roe
Geen lopende functies
Profiel
Matthew D.
Roe worked as a Senior Director of Business Development at Genzyme Pharmaceuticals, Inc. He then worked as the Chief Business Officer at Crescendo Biologics Ltd.
and as a Principal at GSK Plc.
Later, he worked as the Head of Category Marketing at Abcam Plc.
Mr. Roe holds an undergraduate degree from Brunel University and an MBA from Warwick Business School.
Eerdere bekende functies van Matthew D. Roe
| Bedrijven | Functie | Einde |
|---|---|---|
| ABCAM PLC | Verkoop & Marketing | 01-01-2017 |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
Genzyme Pharmaceuticals, Inc.
 Genzyme Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Opleiding van Matthew D. Roe
| Brunel University | Undergraduate Degree |
| Warwick Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GSK PLC | Health Technology |
| ABCAM PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Genzyme Pharmaceuticals, Inc.
Genzyme Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules. The company is headquartered in Cambridge, MA. | Health Technology |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |